DUBLIN (AP) _ Avadel Pharmaceuticals PLC (AVDL) on Friday reported a loss of $63.9 million in its fourth quarter.
The Dublin-based company said it had a loss of $1.72 per share.
The specialty pharmaceutical company posted revenue of $20.9 million in the period.
For the year, the company reported a loss of $95.3 million, or $2.55 per share, swinging to a loss in the period. Revenue was reported as $103.3 million.
The company's shares closed at $2. A year ago, they were trading at $7.16.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL